statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split

Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split PR Newswire REHOVOT, Israel, July 23, 2024...

ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants

ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants ICL and Lavie Bio Leverage Artificial Intelligence to Make...

Lavie Bio Announces Commercial Expansion of Yalos to Winter Wheat

Lavie Bio Announces Commercial Expansion of Yalos to Winter Wheat Lavie Bio Announces Commercial Expansion of Yalos to Winter Wheat PR Newswire REHOVOT, Israel, July 2, 2024 Lavie Bio successfully...

Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country

Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country PR...

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma Biomica Presents Positive Clinical Data Update...

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.

Volume	55,216.00
52-Wk High	$11.00
52-Wk Low	$4.50

EVGN Evogene Ltd

About

Feed

News

Earnings

Fundamentals